Understanding Thyroid Eye Disease – A Comprehensive Clinical Review

Activity Title

Understanding Thyroid Eye Disease - A Comprehensive Clinical Review

Description

By the conclusion of this educational activity, participants should have a deeper understanding of Thyroid Eye Disease (TED). They should be able to distinguish that TED is diagnosed clinically, while Thyroid Disease is diagnosed biochemically. Furthermore, participants should be familiar with the signs and symptoms of TED, the clinical evaluation process for diagnosis, the current treatment options available, and the ongoing clinical trials aimed at enhancing and broadening treatment strategies for Thyroid Eye Disease.

Intended Audience

This activity is intended for clinical and scientific laboratory professionals, physician - scientists who have an interest in thyroid disease.

Learning Objectives

After completing the activity, the participant should be better able to:

Explain the connection between thyroid dysfunction and Thyroid Eye Disease (TED).
Detail the development and progression of TED.
Recognize the signs and symptoms associated with TED.
Develop a diagnostic approach for TED.
Review the available treatment options for TED.

Instruction Level: Intermediate

Speaker

Jody G. Abrams, MD
Neuro-Ophthalmologist and Oculoplastic Surgeon
Sarasota Retina Institute
Sarasota, Florida

Mark A. Lupo, MD
Founder and Medical Director
Thyroid & Endocrine Center of Florida
Florida State University, College of Medicine
Assistant Clinical Professor of Medicine
Sarasota, Florida

Duration

1.5 hours

Release and Expiration Dates

Release Date: August 15, 2025
Expiration Date: August 15, 2027

Disclosures

The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.

Jody G. Abrams, MD
-Consulting Fee (e.g., Advisory Board): Amgen/Horizon, Viridian
-Contracted Research: Amgen/Horizon, Viridian
-Speakers' Bureau: Amgen/Horizon, ANI

Mark A. Lupo, MD
-Consulting: Interpace Diagnostics, Elsai, Abbvie, Horizon Therapeutics
-Contracted Research: Roche, QuidelOrtho, Takeda
-Honoraria: Elsai, Interpace Diagnostics, Abbvie, QuidelOrtho
-Speakers Bureau: Elsai, Interpace Diagnostics, Abbvie, QuidelOrtho

P.A.C.E.^® Accreditation

QuidelOrtho is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.^® Program.

Policy on Privacy and Confidentiality

QuidelOrtho Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. QuidelOrtho Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

QuidelOrtho Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.

Medium Used

This program has been made available online.

Commercial Support Statement

This activity is provided by the QuidelOrtho Corporation.

System Requirements

To view this educational activity, you will need a modern web browser with JavaScript and HTML5. Cookies enabled allows users to proceed through all elements. Some users encounter issues with hand held devices ie. smart phones. In these cases, we recommend the use of computers.

Activity Title